Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

CD8+ T cell states in human cancer: insights from single-cell analysis.

van der Leun AM, Thommen DS, Schumacher TN.

Nat Rev Cancer. 2020 Feb 5. doi: 10.1038/s41568-019-0235-4. [Epub ahead of print] Review.

PMID:
32024970
2.

Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4+ T cells.

Dimeloe S, Gubser P, Loeliger J, Frick C, Develioglu L, Fischer M, Marquardsen F, Bantug GR, Thommen D, Lecoultre Y, Zippelius A, Langenkamp A, Hess C.

Sci Signal. 2019 Sep 17;12(599). pii: eaav3334. doi: 10.1126/scisignal.aav3334.

PMID:
31530731
3.

A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer.

Trefny MP, Rothschild SI, Uhlenbrock F, Rieder D, Kasenda B, Stanczak MA, Berner F, Kashyap AS, Kaiser M, Herzig P, Poechtrager S, Thommen DS, Geier F, Savic S, Jermann P, Alborelli I, Schaub S, Stenner F, Früh M, Trajanoski Z, Flatz L, Mertz KD, Zippelius A, Läubli H.

Clin Cancer Res. 2019 May 15;25(10):3026-3034. doi: 10.1158/1078-0432.CCR-18-3041. Epub 2019 Feb 14.

PMID:
30765392
4.

The First Shall (Be) Last: Understanding Durable T Cell Responses in Immunotherapy.

Thommen DS.

Immunity. 2019 Jan 15;50(1):6-8. doi: 10.1016/j.immuni.2018.12.029.

5.

Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.

Stanczak MA, Siddiqui SS, Trefny MP, Thommen DS, Boligan KF, von Gunten S, Tzankov A, Tietze L, Lardinois D, Heinzelmann-Schwarz V, von Bergwelt-Baildon M, Zhang W, Lenz HJ, Han Y, Amos CI, Syedbasha M, Egli A, Stenner F, Speiser DE, Varki A, Zippelius A, Läubli H.

J Clin Invest. 2018 Nov 1;128(11):4912-4923. doi: 10.1172/JCI120612. Epub 2018 Sep 24.

6.

A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade.

Thommen DS, Koelzer VH, Herzig P, Roller A, Trefny M, Dimeloe S, Kiialainen A, Hanhart J, Schill C, Hess C, Savic Prince S, Wiese M, Lardinois D, Ho PC, Klein C, Karanikas V, Mertz KD, Schumacher TN, Zippelius A.

Nat Med. 2018 Jul;24(7):994-1004. doi: 10.1038/s41591-018-0057-z. Epub 2018 Jun 11.

7.

Digital image analysis improves precision of PD-L1 scoring in cutaneous melanoma.

Koelzer VH, Gisler A, Hanhart JC, Griss J, Wagner SN, Willi N, Cathomas G, Sachs M, Kempf W, Thommen DS, Mertz KD.

Histopathology. 2018 Sep;73(3):397-406. doi: 10.1111/his.13528. Epub 2018 Jun 5.

PMID:
29660160
8.

T Cell Dysfunction in Cancer.

Thommen DS, Schumacher TN.

Cancer Cell. 2018 Apr 9;33(4):547-562. doi: 10.1016/j.ccell.2018.03.012. Review.

9.

Agonistic anti-CD40 therapy synergizes with LAG-3-blocking antibodies
.

Müller P, Thommen DS, Zippelius A.

Int J Clin Pharmacol Ther. 2017 Aug;55(8):692-694. doi: 10.5414/CPXCES15EA06. No abstract available.

PMID:
27641216
10.

Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor.

Schreiner J, Thommen DS, Herzig P, Bacac M, Klein C, Roller A, Belousov A, Levitsky V, Savic S, Moersig W, Uhlenbrock F, Heinzelmann-Schwarz VA, Umana P, Pisa P, von Bergwelt-Baildon M, Lardinois D, Müller P, Karanikas V, Zippelius A.

Oncoimmunology. 2015 Jun 24;5(2):e1062969. eCollection 2016 Feb.

11.

Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade.

Müller P, Kreuzaler M, Khan T, Thommen DS, Martin K, Glatz K, Savic S, Harbeck N, Nitz U, Gluz O, von Bergwelt-Baildon M, Kreipe H, Reddy S, Christgen M, Zippelius A.

Sci Transl Med. 2015 Nov 25;7(315):315ra188. doi: 10.1126/scitranslmed.aac4925.

PMID:
26606967
12.

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors.

Thommen DS, Schreiner J, Müller P, Herzig P, Roller A, Belousov A, Umana P, Pisa P, Klein C, Bacac M, Fischer OS, Moersig W, Savic Prince S, Levitsky V, Karanikas V, Lardinois D, Zippelius A.

Cancer Immunol Res. 2015 Dec;3(12):1344-55. doi: 10.1158/2326-6066.CIR-15-0097. Epub 2015 Aug 7.

13.

Cancer immunology - development of novel anti-cancer therapies.

Rothschild SI, Thommen DS, Moersig W, Müller P, Zippelius A.

Swiss Med Wkly. 2015 Feb 4;145:w14066. doi: 10.4414/smw.2015.14066. eCollection 2015. Review.

14.

Head-to-head comparison of length of stay, patients' outcome and satisfaction in Switzerland before and after SwissDRG-Implementation in 2012 in 2012: an observational study in two tertiary university centers.

Thommen D, Weissenberger N, Schuetz P, Mueller B, Reemts C, Holler T, Schifferli JA, Gerber M, Hug BL.

Swiss Med Wkly. 2014 Jun 25;144:w13972. doi: 10.4414/smw.2014.13972. eCollection 2014.

15.

The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.

Martin K, Müller P, Schreiner J, Prince SS, Lardinois D, Heinzelmann-Schwarz VA, Thommen DS, Zippelius A.

Cancer Immunol Immunother. 2014 Sep;63(9):925-38. doi: 10.1007/s00262-014-1565-4. Epub 2014 Jun 7.

PMID:
24906866
16.

Head-to-head comparison of fee-for-service and diagnosis related groups in two tertiary referral hospitals in Switzerland: an observational study.

Weissenberger N, Thommen D, Schuetz P, Mueller B, Reemts C, Holler T, Schifferli JA, Gerber M, Hug BL.

Swiss Med Wkly. 2013 May 17;143:w13790. doi: 10.4414/smw.2013.13790. eCollection 2013.

17.

Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis.

Cooksley-Decasper S, Reiser H, Thommen DS, Biedermann B, Neidhart M, Gawinecka J, Cathomas G, Franzeck FC, Wyss C, Klingenberg R, Nanni P, Roschitzki B, Matter C, Wolint P, Emmert MY, Husmann M, Amann-Vesti B, Maier W, Gay S, Lüscher TF, von Eckardstein A, Hof D.

PLoS One. 2012;7(10):e47985. doi: 10.1371/journal.pone.0047985. Epub 2012 Oct 24.

18.

Two preferentially expressed proteins protect vascular endothelial cells from an attack by peptide-specific CTL.

Thommen DS, Schuster H, Keller M, Kapoor S, Weinzierl AO, Chennakesava CS, Wang X, Rohrer L, von Eckardstein A, Stevanovic S, Biedermann BC.

J Immunol. 2012 Jun 1;188(11):5283-92. doi: 10.4049/jimmunol.1101506. Epub 2012 Apr 27.

19.

[Colonic intussusception in adults: a case report].

Monek O, Thommen D, Audet M, Simeu B, Jaeck D, Wolf P.

Ann Chir. 1999;53(5):439-42. French. No abstract available.

PMID:
10389335
20.

[Hemostasis parameters in 55 patients with venous and/or arterial thromboembolisms].

Thommen D, Buhrfeind E, Felix R, Sulzer I, Furlan M, Lämmle B.

Schweiz Med Wochenschr. 1989 Apr 22;119(16):493-9. German.

PMID:
2524096
21.

[Birth and expansion of a family planning center].

Thommen DH, Vuilleumier E.

Rev Med Suisse Romande. 1988 Dec;108(12):1059-65. French. No abstract available.

PMID:
3222606
22.

[Measurement of bleeding time and study of thrombocyte aggregation. Standardization of methods, normal values and results in patients with suspected hemorrhagic diathesis].

Thommen D, Sulzer I, Buhrfeind E, Naef R, Furlan M, Lämmle B.

Schweiz Med Wochenschr. 1988 Oct 29;118(43):1559-67. German.

PMID:
3238391
23.

[The menstrual cycle and its pathology].

Novotny M, Thommen DH.

Ther Umsch. 1983 Jul;40(7):577-80. French. No abstract available.

PMID:
6684799
24.

[Sterility caused by malformations of the female urogenital tract (author's transl)].

Brigljevic B, Thommen DH.

Ther Umsch. 1980 Jun;37(6):463-7. French. No abstract available.

PMID:
7423394
25.

[General modifications of the maternal organism during pregnancy].

Thommen D.

Rev Med Suisse Romande. 1979 Oct;99(10):697-702. French. No abstract available.

PMID:
538367
26.

New data and a discussion of infant killing in old world monkeys and apes.

Angst W, Thommen D.

Folia Primatol (Basel). 1977;27(3):198-229.

PMID:
405288
27.

[Jaundice in pregnancy].

Thommen DH.

Rev Med Suisse Romande. 1976 Oct;96(10):743-50. No abstract available.

PMID:
1013547
28.

[Contraception: the point].

Khalil JA, Thommen DH.

Ther Umsch. 1976 Apr;33(4):204-9. French.

PMID:
1006573
29.

[Asymptomatic bacteriuria and its detection during pregnancy].

Thommen DH.

Rev Med Suisse Romande. 1975 Mar;95(3):181-7. French. No abstract available.

PMID:
1166185
30.

[Anemia and pregnancy].

Thommen D.

Rev Med Suisse Romande. 1973 Mar;93(3):189-94. French. No abstract available.

PMID:
4793776
31.

[Cushing' syndrome, uterine myoma and preservation of the uterus, bradycardia and labor. Some clinical cases].

Thommen D.

Bull Fed Soc Gynecol Obstet Lang Fr. 1968 Apr-May;20(2):106-7. French. No abstract available.

PMID:
5761176
32.

[Bradycardia and delivery].

Thommen D.

Gynaecologia. 1968;166(4):344-6. French. No abstract available.

PMID:
5699014
33.

[Cushing's syndrome].

Thommen D.

Gynaecologia. 1968;166(4):341-3. French. No abstract available.

PMID:
5699013
34.

[Uterine myoma and preservation of the uterus].

Thommen D.

Gynaecologia. 1968;166(4):338-40. French. No abstract available.

PMID:
5699012
35.

[Demographic aspects of our times].

Thommen DH.

Rev Med Suisse Romande. 1967 Jan;87(1):15-24. French. No abstract available.

PMID:
5595402
36.

[The use of vallestril in inhibition and suppression of lactation].

THOMMEN DH.

Praxis. 1959 Oct 29;48:1013-5. French. No abstract available.

PMID:
13838053
37.

[Birth control, an important measure used by modern preventive medicine against abortions].

ROSSEL G, THOMMEN D.

Rev Med Suisse Romande. 1957 Jun;77(6):388-95. French. No abstract available.

PMID:
13454257
38.

[Clinical importance of Lewis blood group system].

HASSIG A, MEYER W, THOMMEN D.

Schweiz Med Wochenschr. 1955 Aug 13;85(33):786-7. German. No abstract available.

PMID:
13255832
39.

[Use of a new vaginal contraceptive; polyclinic trials].

THOMMEN DH.

Praxis. 1955 Apr 14;44(15):334-6. French. No abstract available.

PMID:
14384674

Supplemental Content

Loading ...
Support Center